Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

59.86
Delayed Data
As of 4:01pm ET
 -1.45 / -2.37%
Today’s Change
45.45
Today|||52-Week Range
71.60
+1.05%
Year-to-Date
Stock Market News for June 22, 2016
Jun 22 / Zacks.com - Paid Partner Content
AbbVie's Rova-T Update at ASCO: Good or Bad?
Jun 11 / MotleyFool.com - Paid Partner Content
7 Pharmaceutical Stocks With Dividends Yielding More Than 3%
Jun 21 / MotleyFool.com - Paid Partner Content
My Favorite Clinical-Stage Biotech Stocks to Buy
Jun 11 / MotleyFool.com - Paid Partner Content
Watch These 7 Huge Put Purchases In Tuesday Trade
Jun 21 / Benzinga - Paid Partner Content
Biotech Buzz: ASCO Winners and Losers and Biogen's Discouraging Failure
Jun 10 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Johnson & Johnson
Jun 19 / MotleyFool.com - Paid Partner Content
Incyte's Jakafi Positive in Phase III for Polycythemia Study
Jun 10 / Zacks.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Eli Lilly
Jun 15 / MotleyFool.com - Paid Partner Content
Steel stocks rise on 'very bullish' hopes
Jun 08 / FT.com - Paid Partner Content
Infinity (INFI) at 52-Week Low on Disappointing Duvelisib Data
Jun 15 / Zacks.com - Paid Partner Content
M&A back on the table as 'big pharma' targets smaller rivals
Jun 02 / FT.com - Paid Partner Content
Why Infinity Pharmaceuticals Inc. Is Being Obliterated Today
Jun 14 / MotleyFool.com - Paid Partner Content
Cancer doctors face next drug challenge
Jun 01 / FT.com - Paid Partner Content
Amgen's Biosimilar of AbbVie's Humira to Face FDA Panel
Jun 14 / Zacks.com - Paid Partner Content